Mechanism of Cucurbitacin B Targeting ZNF70 / NLRP3 Axis Against Inflammation‐Associated Colorectal Cancer
Phytotherapy Research · 2026-07 · 40 (7) · 4454-4470
DOI: 10.1002/ptr.70329 ↗Kurz gefasst
Fachartikel in der Zeitschrift Phytotherapy Research, online erschienen am 08.05.2026. Verfasst von Shen Cao und 9 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Natural Medicines of the Changbai Mountain (Yanbian University), Ministry of Education; School of Pharmacy, Yanbian University, Yan…. Hauptthemen laut MEDLINE: Triterpenes, NLR Family, Pyrin Domain-Containing 3 Protein, Colorectal Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 53 Literaturangaben. Gefördert von: National Natural Science Foundation of China, The Jilin Province Science and Technology Development Plan Project, Crosswise Tasks.
Abstract (Originalsprache)
Cucurbitacin B is a naturally occurring tetracyclic triterpenoid extracted from plants in the Cucumis melo L. It demonstrates various pharmacological activities, such as hepatoprotective, anti‐inflammatory, and anti‐tumor effects. However, its therapeutic effect on inflammation‐associated colorectal cancer (CRC) and its mechanism of action have not been elucidated. This study is aimed to investigate the effects of cucurbitacin B on inflammation‐associated CRC and the mechanism of action. In vitro, the effect of cucurbitacin B on the inflammatory response and the related ZNF70/NLRP3 pathway was examined using western blotting, CCK‐8, ELISA, and immunofluorescence assays. In the HCT116/THP‐1 supernatant co‐culture system, EdU, colony formation, and wound healing assays were performed to evaluate the effects of cucurbitacin B on the proliferation, migration, and epithelial‐mesenchymal transition (EMT) progression of HCT116 cells in response to inflammation. In vivo, a mouse model of inflammatory CRC was constructed by administering azoxymethane (AOM) and dextran sodium sulfate (DSS). To study the role of ZNF70, an adenoviral vector AAV was used to knock out ZNF70 in mice. High‐performance liquid chromatography (HPLC) was utilized to assess the toxic impact of cucurbitacin B on mice. Our results indicate that cucurbitacin B reduces the expression of NLRP3 inflammasome‐associated proteins by downregulating the production of ZNF70. The co‐culture experiment showed that cucurbitacin B inhibited the proliferation, migration, and EMT of HCT116 cells in the inflammatory microenvironment. In vivo studies demonstrated that the knockdown of ZNF70 restored body weight, improved colon length, reduced tumor burden, and increased survival rate in AOM/DSS model mice. This effect was further enhanced by the addition of cucurbitacin B. The HPLC results showed that cucurbitacin B was non‐toxic to the heart, liver, spleen, lungs, and kidneys of mice. In conclusion, the downregulation of ZNF70 by cucurbitacin B inhibits the activation of NLRP3 inflammasomes and reduces the promoting effect of the inflammatory microenvironment on CRC proliferation, migration, and the EMT process. Our findings may provide new insights for the development of treatments for inflammation‐associated CRC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Natural Medicines of the Changbai Mountain (Yanbian University), Ministry of Education; School of Pharmacy, Yanbian University, Yanji, Jilin Province, China.
- Key Laboratory of Drug Targets and Pharmacological Screening in Colleges and Universities of Jilin Province; Yanbian University, Yanji, Jilin Province, China.
- Molecular Medicines Research Center, School of Pharmacy, Yanbian University, Yanji, Jilin Province, China.
- College of Pharmacy, Seoul National University, Seoul, South Korea.
- Cancer Research Institute, Seoul National University, Seoul, South Korea.
ORCID-Profile: Yue Xing, Xuejun Jin, Juan Ma
Förderung
- National Natural Science Foundation of China
- The Jilin Province Science and Technology Development Plan Project
- Crosswise Tasks
Zitieren
APA
Cao, S., Tai, Y., Wang, Y., Han, J., Li, M. Y., Surh, Y. J., Xing, Y., Zuo, H. X., Jin, X., & Ma, J. (2026). Mechanism of Cucurbitacin B Targeting ZNF70 / NLRP3 Axis Against Inflammation‐Associated Colorectal Cancer. Phytotherapy Research, 40(7), 4454-4470. https://doi.org/10.1002/ptr.70329
Vancouver
Cao S, Tai Y, Wang Y, Han J, Li MY, Surh YJ, et al. Mechanism of Cucurbitacin B Targeting ZNF70 / NLRP3 Axis Against Inflammation‐Associated Colorectal Cancer. Phytotherapy Research. 2026;40(7):4454-4470. doi:10.1002/ptr.70329
BibTeX
@article{Cao2026,
author = {Cao, Shen and Tai, Yi and Wang, Yuhan and Han, Jing and Li, Ming Yue and Surh, Young Joon and Xing, Yue and Zuo, Hong Xiang and Jin, Xuejun and Ma, Juan},
title = {Mechanism of Cucurbitacin B Targeting ZNF70 / NLRP3 Axis Against Inflammation‐Associated Colorectal Cancer},
journal = {Phytotherapy Research},
year = {2026},
volume = {40},
number = {7},
pages = {4454--4470},
doi = {10.1002/ptr.70329}
}
EUVIMED